Neuraxpharm Boosts Branded Business With Established Sanofi Portfolios

Latest Acquisition Should See Firm’s Annual Gross Sales Expand To €600m

 
• By Chloe Kent
  
Graphic depiction of central nervous system
Neuraxpharm has purchased two portfolios of CNS, pain and vascular disease products • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business